Journal Article Summary
The article focuses on developing a new method to efficiently screen medications for their effectiveness in helping people quit smoking. This topic is crucial because smoking remains a leading cause of preventable death, and many smokers want to quit but struggle to do so. The authors emphasize the need for a streamlined process to identify which new medications are worth further testing, as traditional methods can be time-consuming and costly.
In their research, the authors tested three FDA-approved smoking cessation medications—nicotine patches, varenicline, and bupropion—against a placebo in a series of studies. They employed a crossover design, where participants tried both the active medication and placebo in separate weeks, allowing for direct comparisons within the same individuals. The results showed that the medications significantly increased the number of days participants abstained from smoking, particularly among those who were highly motivated to quit. In contrast, modafinil, a medication known not to aid smoking cessation, did not show any effectiveness, confirming the method's ability to distinguish between effective and ineffective treatments.
However, the study has limitations, including the potential difficulty in applying this method to medications that require longer periods to take effect or to be cleared from the body. Patients should be aware that while this new screening procedure shows promise, it is still in the research phase and not yet a standard practice. It is important for individuals considering smoking cessation medications to discuss their options with a healthcare professional, who can provide personalized advice and support based on the latest research and their specific circumstances.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Perkins Kenneth A., Lerman Caryn. AN EFFICIENT EARLY PHASE 2 PROCEDURE TO SCREEN MEDICATIONS FOR EFFICACY IN SMOKING CESSATION. Psychopharmacology 2013. DOI: 10.1007/s00213-013-3364-6. PMID: 24297304. PMCID: PMC3910509.
Featured Pill Pals Product
Bupropion 100 mg Sustained Release (SR) Tablets --- Generic For Wellbutrin SR --- Camber
Bupropion 100 mg Sustained Release (SR) Tablets — Generic For Wellbutrin SR — Camber is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
